PeptideMark
PeptidesResearchGuidesLearnNewsToolsAbout
HomeNewsBreaking

News topic

Breaking News & Updates

Breaking coverage from PeptideMark.

2 articles in this topic

Breaking2026-07-03 12 min

PCAC July 23-24: FDA Recommends Against All 7 Peptides — What the Briefing Documents Reveal

The FDA has released its briefing documents for the July 23-24 PCAC meeting, and the agency's position is clear: do not add any of the seven peptides under review to the 503A Bulks List. But with an advisory panel reshaped by RFK Jr. to include peptide clinic doctors, the committee's vote may go the other way. Here's what the documents say and what it means.

Breaking2026-07-03 8 min

Medicare GLP-1 Bridge Just Launched: $50/Month Wegovy and Zepbound — Who Qualifies

As of July 1, 2026, Medicare beneficiaries can access GLP-1 weight loss drugs for a fixed $50 monthly copay through the new Medicare GLP-1 Bridge program. This is the first time Medicare has covered drugs prescribed solely for obesity. Here's who qualifies, what's covered, and how to enroll.

Browse other news topics

AnalysisClinical TrialsComparisonGuideIndustryNewsRegulatoryResearchSafety

Medical disclaimer: PeptideMark is for educational purposes only. This is not medical advice, diagnosis, or treatment. Always verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Read full disclaimer

Popular Peptides

  • All Peptides
  • BPC-157
  • Semaglutide
  • Tirzepatide
  • MK-677
  • TB-500
  • CJC-1295
  • Ipamorelin
  • GHK-Cu
  • PT-141
  • Sermorelin
  • Tesamorelin
  • Epithalon
  • Selank
  • Semax
  • Retatrutide
  • MOTS-c
  • Melanotan II
  • AOD-9604
  • NAD+
  • Thymosin Alpha-1

Categories

  • Healing & Recovery
  • Weight Loss
  • Growth Hormone
  • Skin & Hair
  • Sexual Health
  • Longevity
  • Nootropic
  • Metabolic
  • Immune
  • Gut Health

Guides & Learning

  • Best Peptides by Goal
  • Best for Weight Loss
  • Best for Muscle Recovery
  • Best for Growth Hormone
  • Research Library
  • Mechanisms of Action
  • By Condition
  • Side Effects
  • Glossary
  • Guides
  • Injection Sites
  • Half-Life Reference
  • Needle & Syringe
  • Dosing Timing
  • Learn
  • News
  • Tools
  • Sitemap
  • FDA Tracker
  • Compare Tool
  • Peptide Quiz
  • Dosage Reference

Company

  • About
  • Advertise
  • Find a Clinic

Legal

  • Privacy
  • Terms
  • Medical Disclaimer
  • FTC Disclosure
PeptideMark

© 2026 PeptideMark. Independent peptide research resource.